Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 5 Finished
-
Parallel-group randomized controlled trial of Pioglitazone versus empagliflozin for T3cDM: The PEP-DM Trial
Kudva, Y. C. (PI) & Yadav, D. (CoPI)
National Institute of Diabetes and Digestive and Kidney Diseases
8/1/24 → 5/31/25
Project: Research project
-
A Randomized Cross-Over Trial Evaluating Automated Insulin Delivery Technologies on Glycemic Outcomes and Quality of Life in Older Adults with Type 1 Diabetes
Henderson, R. J. (PI), Miller, K. (CoPI), Rickels, M. R. (CoPI), Chaytor, N. S. (CoPI), Pratley, R. E. (CoPI), Weinstock, R. S. (CoPI) & Kudva, Y. C. (CoPI)
National Institute of Diabetes and Digestive and Kidney Diseases
7/25/19 → 4/30/24
Project: Research project
-
Automated Glucose Regulation to improve Diabetes Control and Outcomes for Pregnant Women with Type 1 Diabetes and Fetus
Dassau, E. (PI), Kudva, Y. C. (CoPI) & Rosenn, B. M. (CoPI)
National Institute of Diabetes and Digestive and Kidney Diseases
9/30/18 → 5/31/21
Project: Research project
-
Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) Trial
Kovatchev, B. (PI), Anderson, S. M. (CoPI), Doyle, F. J. (CoPI), Kudva, Y. C. (CoPI) & Levy, C. (CoPI)
National Institute of Diabetes and Digestive and Kidney Diseases
1/1/16 → 5/31/21
Project: Research project
-
Integrated Approaches to Close the Loop in Type 1 Diabetes
Basu, A. (CoPI) & Kudva, Y. C. (CoPI)
9/30/09 → 4/30/24
Project: Research project
-
A 13-Week Single-Arm Evaluation of Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes
for the INHALE-3 Study Group, Mar 1 2025, In: Diabetes Technology and Therapeutics. 27, 3, p. 161-169 9 p.Research output: Contribution to journal › Article › peer-review
-
Automated Insulin Delivery in Elderly with Type 1 Diabetes: A Prespecified Analysis of the Extension Phase
for the AIDE study group, 2025, (Accepted/In press) In: Diabetes Technology and Therapeutics.Research output: Contribution to journal › Article › peer-review
-
Benefits of Glucagon-like Peptide-1 Receptor Agonists After Kidney Transplantation
Sahi, S. S., Garcia Valencia, O., Na, J., Lemke, A., Duffy, D., Smith, B., Navratil, P., Budhiraja, P., Diwan, T. S., Issa, N., Stegall, M. D., Denic, A., Abdelrheem, A. A., Wadei, H. M., Park, W. D., Shah, P., Kudva, Y. C. & Kukla, A., Jun 2025, In: Endocrine Practice. 31, 6, p. 798-804 7 p.Research output: Contribution to journal › Article › peer-review
-
Clinical and Radiological Fusion: A New Frontier in Predicting Post-Transplant Diabetes Mellitus
Budhiraja, P., Smith, B. H., Kukla, A., Kline, T. L., Korfiatis, P., Stegall, M. D., Jadlowiec, C. C., Cheungpasitporn, W., Wadei, H. M., Kudva, Y. C., Alajous, S., Misra, S. S., Me, H. M., Rios, I. P. & Chakkera, H. A., 2025, In: Transplant International. 38, 14377.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Utility of Serum C-Peptide Concentration for Hospitalized Patients with Hyperglycemia
Costa, D. N., Kudva, Y. C., Jensen, M. D. & Shah, P., Feb 1 2025, In: Diabetes Technology and Therapeutics. 27, 2, p. 121-127 7 p.Research output: Contribution to journal › Article › peer-review